Schedule 13G ownership disclosure
CERECOR INC
Security class unavailable · CUSIP: 15671L109
Event date: 2018-09-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-014042
- Form type
- SC 13G
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Oct 03, 2018
- Reporting period
- Sep 25, 2018
- Description
- Schedule 13G beneficial ownership